The Prevalence of p16 Expression in Urothelial Bladder Cancer in a Tertiary Care Hospital of Chattogram, Bangladesh

BACKGROUND & OBJECTIVE: p16 is a tumor suppressor gene, loss of which is usually associated with poor epithelial differentiation, resulting in tumor progression, which correlates with aggressive clinical behavior and poor prognosis. CDK 4/6 inhibitors can be used as a therapeutic target in p16 n...

Descripción completa

Detalles Bibliográficos
Autores principales: Farnaz, Taniza, Bhattacharjee, Pradip, Ahamad, M. Shahab Uddin, Rima, , Sharmin Ashraf, Momin, Naznin Nahar, Sadaf, Anika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628371/
https://www.ncbi.nlm.nih.gov/pubmed/37942193
http://dx.doi.org/10.30699/IJP.2023.1987551.3070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628371/
https://www.ncbi.nlm.nih.gov/pubmed/37942193
http://dx.doi.org/10.30699/IJP.2023.1987551.3070

Ejemplares similares